A physics-informed machine learning framework for predicting and mitigating doxorubicin nanocarrier toxicity in

Abbas Rahdar1, Sonia Fathi-Karkan2,3,4

  • 1Department of Physics, University of Zabol, Zabol, Iran. a.rahdar@uoz.ac.ir.

Scientific Reports
|March 28, 2026
PubMed

Insights

This study developed a hybrid computational framework using machine learning to predict and optimize doxorubicin (DOX) nanocarrier safety. The physics-informed neural network model accurately guides the design of safer chemotherapy delivery systems.

Area of Science:

  • Biomedical Engineering
  • Computational Chemistry
  • Nanotechnology

Background:

  • Doxorubicin (DOX) efficacy is limited by dose-dependent systemic toxicity, particularly cardiotoxicity.
  • Nanocarrier systems offer solutions but optimizing their complex physicochemical properties for biological outcomes is challenging.

Purpose of the Study:

  • To develop a hybrid computational framework integrating classical and physics-informed machine learning (PIML) to predict and optimize the cytotoxicity of DOX-loaded nanocarriers toward normal cells.
  • To identify key physicochemical properties governing nanocarrier safety and establish an optimal design space for reduced toxicity.

Main Methods:

  • Compiled an extensive dataset of 77 nanocomposite systems with physicochemical and biological data.
  • Trained and compared various machine learning (ML) models, including a Physics-Informed Neural Network (PINN) incorporating drug release kinetics, colloidal stability, and diffusion.
  • Utilized SHAP analysis for feature importance and Bayesian optimization for design space exploration.

Main Results:

  • The PINN model demonstrated superior predictive capability (R² = 0.89, RMSE = 0.14) over conventional ML methods.
  • Zeta potential and particle size were identified as the most critical factors influencing cytotoxicity.
  • An optimal design space was determined: sizes of 120-150 nm, zeta potentials of -25 to -35 mV, loading efficiency of 5-10%, and encapsulation efficiency >85%.

Conclusions:

  • The proposed PIML framework provides a robust and interpretable method for rational nanocarrier design.
  • This approach significantly enhances the development of safer chemotherapeutic delivery systems by minimizing empirical optimization.
  • Experimental validation confirmed the model's accuracy, with prediction errors below 3%.